Cite
HARVARD Citation
Rozga, P. et al. (2020). Novel engineered TRAIL‐based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance. International journal of cancer. 147 (4), pp. 1117-1130. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rozga, P. et al. (2020). Novel engineered TRAIL‐based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance. International journal of cancer. 147 (4), pp. 1117-1130. [Online].